Niquitin Mint (Nicotine Resinate)

Nicotine resinate is used in smoking cessation therapy to address nicotine dependence.

• Smoking cessation: helps reduce cravings and withdrawal symptoms in adults attempting to quit smoking.
• Nicotine dependence: supports gradual reduction of nicotine intake as part of a structured quit plan.
• Tobacco use disorder: assists individuals in managing urges associated with habitual tobacco use.

• Nicotine resinate acts as an agonist at nicotinic acetylcholine receptors located in the oral mucosa. By stimulating these receptors, it delivers low, controlled doses of nicotine, which mitigates the neurochemical deficit that occurs during tobacco abstinence. This reduces the intensity of withdrawal symptoms and cravings, facilitating a smoother transition away from combustible cigarettes.

Niquitin Mint may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Mouth irritation or tingling
• Nausea
• Hiccups
• Dizziness
• Headache
• Increased salivation

Serious or Rare Side Effects

• Throat swelling or difficulty breathing
• Severe allergic reaction (rash, itching, swelling)
• Cardiovascular events such as hypertension or arrhythmia
• Persistent vomiting
• Chest pain
• Unexplained fainting

Before using Niquitin Mint, consider the following precautions to ensure safe and effective use.

• Assess cardiovascular status: evaluate for hypertension or heart disease before initiating therapy.
• Use under medical supervision: follow prescriber guidance on duration and tapering.
• Avoid if allergic to nicotine: discontinue immediately if hypersensitivity occurs.
• Not for non‑smokers or occasional smokers: product is intended for regular tobacco users seeking cessation.
• Keep away from children: store out of reach to prevent accidental ingestion.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Nicotine resinate can interact with other medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): combined use may increase hypertensive risk.
• Cardiac glycosides: nicotine may potentiate cardiac effects.
• Other nicotine replacement products: risk of nicotine overdose.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents: nicotine may counteract blood pressure‑lowering effects.
• Caffeine: concurrent use may enhance stimulant effects.
• Alcohol: may increase nicotine cravings and side effects.
• Certain antidepressants (e.g., bupropion): may require dose adjustment.